ArticleTherapeutic advances in hematology2025
Comparative analysis of once-weekly versus twice-weekly carfilzomib in relapsed and refractory multiple myeloma: a meta-analysis.
Wenhao Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.